Zevra TherapeuticsZVRA
那斯達克 · USD
13.50
-0.16
(-1.17%)
收盤 06/11 03:59 (UTC+8)
盤後
13.29
13.29
(-1.59%)
06/11 03:59 (UTC+8)
Zevra TherapeuticsZVRA
13.50
-0.16
(-1.17%)
財務數據
損益表
- 0.13
- 0.03
- 0.04
- 0.04
- 0.12
- 0.20
- 0.26
- 0.26
- 0.34
- 0.80
- 397.31
- -73.49
- 29.90
- -16.95
- 225.93
- 69.40
- 26.86
- 0.70
- 30.93
- 133.07
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | |
營業收入淨額 | 79,534 | 34,125 | 26,063 | 25,881 | 20,401 | 12,043 | 3,695 | 4,449 | 3,425 | 12,920 |
營業成本 | 2,213 | 1,836 | 1,553 | 72,705 | 2,960 | 2,982 | 3,848 | 5,119 | 1,703 | 1,999 |
營業毛利 | 77,321 | 32,289 | 24,510 | -46,824 | 17,441 | 9,061 | -153 | -670 | 1,722 | 10,921 |
營業費用 | 25,175 | 22,974 | 20,367 | 24,215 | - | - | - | - | - | 26,078 |
研發費用 | 4,392 | 2,620 | 3,432 | 3,433 | 3,258 | 8,352 | 10,945 | 10,521 | 12,277 | 11,421 |
推銷及管理費用 | 20,783 | 20,354 | 16,935 | 20,782 | 19,545 | 16,125 | 16,208 | 12,604 | 9,931 | 14,657 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | 52,146 | 9,315 | 4,143 | -71,039 | -5,362 | -15,416 | -27,306 | -23,795 | -20,486 | -15,157 |
其他收入及費用 | -5,631 | 5,299 | -3,069 | 149,954 | 5,414 | -2,758 | -3,607 | 6,050 | 4,529 | -3,979 |
利息費用 | 1,711 | 1,948 | 2,051 | 2,009 | 1,969 | 2,194 | 2,312 | 2,110 | 735 | 756 |
稅前純益 | 44,804 | 12,666 | -977 | 76,906 | -1,917 | -20,368 | -33,225 | -19,855 | -16,692 | -19,892 |
所得稅 | 6,914 | 501 | -433 | 2,199 | 1,182 | 15,371 | - | 70 | -70 | - |
稅後純益 | 37,890 | 12,165 | -544 | 74,707 | -3,099 | -35,739 | -33,225 | -19,925 | -16,622 | -19,892 |
基本每股稅後盈餘(元) | 0.62 | 0.23 | -0.01 | 1.24 | -0.06 | -0.71 | -0.69 | -0.48 | -0.40 | - |
稀釋每股稅後盈餘(元) | 0.60 | 0.19 | -0.01 | 1.22 | -0.06 | -0.69 | -0.72 | -0.47 | -0.40 | -0.54 |
基本平均股數(千股) | 58405.00 | 56419.00 | 55951.00 | 54780.00 | 54095.00 | 53519.00 | 47808.00 | 41899.00 | 41778.00 | - |
稀釋平均股數(千股) | 60230.00 | 62680.00 | 55951.00 | 56324.00 | 54095.00 | - | 47808.00 | 41899.00 | 41778.00 | - |
還原基本每股稅後盈餘(元) | 0.62 | 0.23 | -0.01 | 1.24 | -0.06 | -0.71 | -0.69 | -0.48 | -0.40 | - |
還原稀釋每股稅後盈餘(元) | 0.60 | 0.19 | -0.01 | 1.22 | -0.06 | -0.69 | -0.72 | -0.47 | -0.40 | -0.54 |
還原基本平均股數(千股) | 58,405 | 56,419 | 55,951 | 54,780 | 54,095 | 53,519 | 47,808 | 41,899 | 41,778 | - |
還原稀釋平均股數(千股) | 60,230 | 62,680 | 55,951 | 56,324 | 54,095 | - | 47,808 | 41,899 | 41,778 | - |
EBITDA(千元) | 46,259 | 14,119 | 255 | 79,811 | 1,396 | -17,416 | -29,296 | -16,183 | -14,395 | -18,349 |